Detalhe da pesquisa
1.
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe.
Hematol Oncol
; 40(3): 370-380, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35168291
2.
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
J Oncol Pharm Pract
; 26(3_suppl): 22-32, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268828
3.
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.
J Oncol Pharm Pract
; 26(3_suppl): 3-10, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268831
4.
Can doctors identify older patients at risk of medication harm following hospital discharge? A multicentre prospective study in the UK.
Br J Clin Pharmacol
; 84(10): 2344-2351, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29957885
5.
Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK.
Br J Clin Pharmacol
; 84(8): 1789-1797, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790202
6.
Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study).
BMC Geriatr
; 16: 22, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26787530
7.
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe.
EJHaem
; 4(1): 45-54, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819165
8.
Medication-related harm in older adults following hospital discharge: development and validation of a prediction tool.
BMJ Qual Saf
; 29(2): 142-153, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527053